Patient Pathfinder: Clinical Trials

Clinical Trial Finder AL Amyloidosis Trials

Clinical Trials for AL Amyloidosis

See Locations Near You

There are 21 active AL Amyloidosis trials

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving ABBV-383 as an Intravenous (IV) Infusion

Study Type: Interventional Phase 1

A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis

Study Type: Interventional Phase 3

A Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) Amyloidosis

Study Type: Interventional Phase 2

Daratumumab Maintenance Therapy for Improving Survival in Patients With Light Chain Amyloidosis, EMILIA Trial

Study Type: Interventional Phase 2

Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain Amyloidosis

Study Type: Interventional Phase 1

A Study to Evaluate the Efficacy and Safety of Birtamimab in Mayo Stage IV Patients With AL Amyloidosis

Study Type: Interventional Phase 3

Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL Amyloidosis

Study Type: Interventional Phase 3

Phase 1/2 Study of ZN-d5 for the Treatment of Relapsed or Refractory Light Chain (AL) Amyloidosis

Study Type: Interventional Phase 1

There are 21 active AL Amyloidosis trials

Filter Results

Phase

Study Type

Need more help finding a clinical trial that's the right fit?

Explore our Clinical Trial Finder.

Start Now

Need more help finding a clinical trial that's the right fit?

Explore our Clinical Trial Finder.

Start Now
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider